Lakshmi Yatham


Relevant Degree Programs

Affiliations to Research Centres, Institutes & Clusters


Graduate Student Supervision

Doctoral Student Supervision (Jan 2008 - May 2021)
Executive function deficits in bipolar I disorder: Association with brain structure, illness progression, and antipsychotic medication (2013)

Executive function impairments are a core feature of Bipolar I Disorder (BDI), present not only during acute episodes but also persisting following remission of mood symptoms. Despite advances in knowledge regarding the neural basis of executive functions (EF) in healthy subjects, particularly in regards to the role of the dorsolateral prefrontal cortex (DLPFC) and caudate; research into how changes within these regions contribute to the deficits in BDI is lacking. This thesis explores EF in patients early in the course of illness, examining how impairments evolve with illness progression and how this may relate to neuromorphological changes and naturalistic pharmacological treatment regimes.The first analysis demonstrates that EF is moderate-severely impaired in patients with BDI even following sustained symptomatic recovery from their first manic episode. Both larger caudate size and treatment with a higher relative dose of an antipsychotic drug predicted the severity of deficits. Despite receiving ongoing clinical care, half of patients experienced a subsequent hypo/manic and/or depressive episode within one year. While those who remained well did show significant improvements in EF compared to those whose illness progressed, both patient groups still maintained moderate deficits compared to healthy subjects at follow-up. Although not directly associated with cognitive changes, sustained recovery during this time was also associated with reduced grey matter loss (including the left DLPFC) when compared affective recurrence, even after accounting for other clinical or treatment factors.Maintenance pharmacological treatment with an antipsychotic is commonly used to prevent episode recurrence in BDI. Drugs within this class each show varying affinity to the dopamine D₂ receptor (D₂R), which plays an important modulatory role in DLPFC and caudate function. Differences in D₂R binding have a likely impact on EF, as patients receiving an antipsychotic with high D₂R affinity (risperidone) showed larger impairments when compared to those treated with a low affinity drug (quetiapine) or no antipsychotic.These results demonstrate that illness related structural changes in the DLPFC and caudate are associated with the presence and evolution of executive function deficits in BDI; although the potential confounding effects of antipsychotics which influence functioning in these regions must also be considered.

View record

Neurobiological Correlates of Overweight and Obesity in People with Bipolar Disorder (2013)

Up to 75% of people with bipolar disorder (BD) are overweight or obese, and these patients suffer more severe psychiatric symptoms than normal-weight patients, including more frequent depressions, more suicide attempts, lower response rates to pharmacotherapy, and greater cognitive impairment. Obesity is a chronic inflammatory condition that damages numerous body organs and is causally linked to the development of diabetes, heart disease, and cancer. BD is fundamentally a brain illness, and this, along with converging evidence from human and animal studies suggesting that the brain is a target organ for obesity-related damage, compelled me to investigate obesity-related neurobiological changes early in BD. I found that at recovery from their first manic episode, there was no difference between BD patients and age- and gender-matched healthy subjects in mean body mass index (BMI) or rates of overweight or obesity. Nonetheless, magnetic resonance imaging (MRI) demonstrated that overweight/obese patients had reduced white matter and temporal lobe volumes compared to normal-weight patients. WM reductions are characteristic of early-stage BD, while temporal lobe reductions are frequently reported later in the illness. These findings thus suggested a testable hypothesis: that the neuropathology of BD is exacerbated with elevated BMI. Subsequent investigations supported this hypothesis. A voxel-based analysis of regional brain volumes revealed that BMI-related volume reductions primarily affected frontal, temporal, and subcortical emotion-generating and –regulating brain areas implicated in BD. Moreover, MR spectroscopy showed that overweight/obese patients had reduced hippocampal N-acetylaspartate concentrations compared to normal-weight patients. Similar findings were not detected in overweight/obese healthy subjects, who had reduced occipital lobe grey matter volume and no neurochemical alterations. These are the first data to establish a relationship between elevated BMI and neurobiological alterations in BD, or any psychiatric illness. They demonstrate that elevated BMI is associated with unique brain changes early in BD that negatively impact regions believed to be vulnerable in the illness. This immediately suggests an explanation for the more severe illness course experienced by obese BD patients, and creates a compelling argument for examining the neurobiological impact of obesity in other mental illnesses with high obesity rates, such as major depressive disorder and schizophrenia.

View record

Master's Student Supervision (2010 - 2020)
Cognitive functioning in bipolar disorder: the influence of sex (2013)

Following a wave of similar research conducted in samples with schizophrenia, there has been a recent surge of studies investigating sex differences in the phenomenology of bipolar disorder (BD). These studies have almost exclusively focused on sex differences in course and clinical presentation. As compared with male BD patients, women with BD have increased likelihood of experiencing rapid cycling, mixed mania, suicidal ideation, and a medical or psychiatric comorbidity. However, in addition to its characteristic affective disturbance, the phenomenology of BD is associated with significant and persistent cognitive impairment. There is evidence to support that sexual dimorphisms, the basis of sex differences in cognitive functioning, are altered in BD. Additionally, it has been found that healthy patterns of cognitive sex differences are disrupted in schizophrenia, a closely related illness to BD. Despite this evidence, there have been few studies that have investigated the influence of sex on cognitive functioning in BD; the results that are available are both scant and contradictory. In order to clarify whether sex influences cognitive functioning in BD, 66 patients with BD-I disorder and 105 matched healthy controls were tested on a broad battery of neuropychological tests. As patients used in this sample were tested immediately proceeding symptomatic remission from their first-manic episode, this experimental design is poised to assess sex differences in cognitive functioning early in the course of BD. Overall, unlike in schizophrenia, healthy patterns of cognitive sex differences are intact early in the course of BD. To supplement and contextualize the study presented above, a large portion of this thesis is dedicated to providing literature reviews of the following topics: sex differences in the clinical phenomenology of BD, cognitive impairment in BD, sex differences in cognitive impairment and their neurobiological underpinnings in healthy samples.

View record

Current Students & Alumni

This is a small sample of students and/or alumni that have been supervised by this researcher. It is not meant as a comprehensive list.

Membership Status

Member of G+PS
View explanation of statuses

Program Affiliations



If this is your researcher profile you can log in to the Faculty & Staff portal to update your details and provide recruitment preferences.


Explore our wide range of course-based and research-based program options!